(Q34344263)

English

Reevaluation of antibiotic breakpoints

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

title

Reevaluation of antibiotic breakpoints (English)

1 reference

stated in

Europe PubMed Central

1 August 2017

Phillips I

1

1 reference

stated in

Europe PubMed Central

PubMed ID

11519009

retrieved

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

stated in

Europe PubMed Central

1 August 2017

Clinical Infectious Diseases

1 reference

stated in

Europe PubMed Central

1 August 2017

33 Suppl 3

1 reference

stated in

Europe PubMed Central

1 August 2017

S230-2

1 reference

stated in

Europe PubMed Central

1 August 2017

European standards for antibiotic susceptibility testing: towards a theoretical consensus

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1086%2F321853

retrieved

21 January 2018

The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1086%2F321853

retrieved

21 January 2018

Identifiers

DOI

10.1086/321853

1 reference

stated in

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

PubMed ID

11519009

retrieved

1 August 2017

ResearchGate publication ID

11826712

0 references

(Q34344263)

Reevaluation of antibiotic breakpoints

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)